ABVN Phase 2 - PENFS
NCT: NCT07856446 · COMPLETED
Brief Summary
The vagus nerve is a nerve that controls many bodily functions, including stomach function. Investigators hope that electrically stimulating the nerve around the external ear will also stimulate the internal vagus nerve. If it does, then investigators hope that this may lead to additional treatment options for patients with nausea and vomiting and disordered stomach function. The overall purpose of the ABVN Phase 2 grant is to expand on previous work evaluating the effects of noninvasive stimulation on vagal nerve function. This will be accomplished through several independent, but related, studies. In this study, investigators will evaluate the effect of percutaneous electrical field stimulation on the vagus nerve in healthy subjects. \[This study was originally described in NCT06491758, however a separate record has been created to more accurately reflect the independence of the individual studies supported by the ABVN 2 grant.\]
Frequently Asked Questions
What is ABVN Phase 2 - PENFS?
ABVN Phase 2 - PENFS is a clinical trial registered under NCT07856446. Current status: COMPLETED.
What is the status of NCT07856446?
The current status of NCT07856446 (ABVN Phase 2 - PENFS) is: COMPLETED.
When did ABVN Phase 2 - PENFS start?
ABVN Phase 2 - PENFS started on 2021-10-08.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.